Drugs / PNT001
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04677829 | Mar → Apr 2021 | traumatic brain injury | Pinteon Therapeutics, Inc | Terminated | No outcome recorded |
| Phase 1 | NCT04096287 | Sep 2019 → Feb 2021 | — | Pinteon Therapeutics, Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PNT001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04096287 ↗ |
| Route | Intravenous | “Study medication will be administered as a single i.v. infusion over 30 minutes” NCT04096287 ↗ |